IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in the following conferences: William Blair Growth Stock Conference Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Tuesday, June 4, 2024, at 1:20 p
Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) just released its latest first-quarter results and things are looking...
Tarsus Pharmaceuticals ( NASDAQ:TARS ) First Quarter 2024 Results Key Financial Results Revenue: US$27.6m (up by...